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624a Tuesday, February 18, 2014carboxylate-modified polystyrene nanoparticles were studied as a model sys-
tem. Although both cationic and anionic nanoparticles form a protein corona,
cellular binding follows opposite trends as determined from fluorescence
microscopy experiments. The cellular binding of cationic nanoparticles is
enhanced in the presence of serum proteins, while anionic nanoparticle bind-
ing is inhibited by the presence of serum proteins. Competition assays per-
formed with flow cytometry enabled us to identify the cellular receptors
used by the nanoparticle-protein complexes. We have determined that com-
plexes formed with anionic nanoparticles bind to native protein receptors,
while those formed with cationic nanoparticles bind to scavenger receptors.
Similar trends were observed for anionic nanoparticles with biomedical
applications including quantum dots, Au nanospheres, and low-density lipo-
protein. To probe the underlying cause for the charge-dependent differences
in cellular binding, we are currently characterizing the structure of the
adsorbed proteins using circular dichroism, fluorescence spectroscopy, and
isothermal titration calorimetry. Preliminary results suggest that protein struc-
ture is lost upon binding to cationic nanoparticles, and protein structure is
retained on anionic nanoparticle surfaces. Our results indicate that, in the pres-
ence of blood serum proteins, initial nanoparticle surface charge mediates
nanoparticle-cell interactions.
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Osteoarthritis (OA), a degenerative joint disease, is a large and quickly growing
socioeconomic burden. Disease-modifying drugs are not available for symp-
tomatic OA, and detection of early, asymptomatic OA presents a significant
challenge. Molecular biomarkers found in the joint’s synovial fluid (SF) have
demonstrated a significant potential for early OA detection. However, obtain-
ing this viscous fluid from a joint is difficult and the procedure is not always
successful.
Our new technology allows collection of OA biomarkers directly from SF
without the need to remove any portion of it. The technique utilizes unique
magnetic properties of the superparamagnetic iron oxide nanoparticles
(SPIONs). In the absence of an external magnetic field, SPIONs do not retain
stable magnetization; however when a high-gradient magnetic field is applied,
SPIONs experience a translational force directed towards the field source.
SPION-based materials are safe and efficient. They have been approved by
the FDA for use as contrast agents in MRI.
Our technology uses SPIONs embedded into polymer cores. An antibody
against an OA biomarker is conjugated to the surface of the core. When
particles are injected in SF, they bind OA biomarkers. The biomarker-loaded
particles are then collected with a small Nd-Fe-B magnetic probe. After collec-
tion, the particles are released from the probe and the amounts of collected
biomarker and particles are determined. Then initial concentration of bio-
marker and its total amount in SF are estimated using the magnetic collection
results.
For the proof-of-concept, a widely-investigated OA biomarker, C-telopeptide
of type II collagen (CTXII) was used. The stages of magnetic collection
including antibody-biomarker binding, magnetic collection efficiency, bio-
marker and particle release techniques, and biomarker and particle quantifica-
tion, are characterized in detail. Thereby we demonstrate the potential of our
technolgy to serve as an enabling technology for early OA diagnosis.
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Excessive mucus production is a common and significant problem for several
prominent human lung diseases such as asthma and chronic obstructive pul-
monary disease (COPD). In these diseases, the mucus barrier poses a signif-
icant challenge to drug delivery, leading to increased healthcare cost and poor
quality of life for patients. One method of overcoming structural and fluid
resistance of mucus is by utilizing a targeted delivery method of magnetic
nanoparticles (NPs) to diseased epithelial cells. However, previous experi-
mental studies showed no mucus penetration using superparamagnetic iron
oxide (Fe3O4) FeNPs. In our experiments we generated a field gradient that
is an order of magnitude stronger than that in previously applied FeNPdelivery systems. In our delivery system, FeNPs successfully penetrated the
approximately 100 mm thick mucus layer of air-liquid interface cultured pri-
mary normal human tracheobronchial epithelial cells indicating the potential
of magnetic nanoparticles for targeted drug delivery to the airway mucosal
surface.
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Efficient encapsulation, targeted delivery, and controlled release of drugs
are critical prerequisites in current efforts to design advanced drug delivery
systems. In particular, the development of release-controllable delivery
systems is of importance to curb a substantial risk of systemic side effects
and greatly enhance pharmacological effect of drugs at the desired target.
In this study, we have developed a novel mesoporous silica-based delivery
system in which the function of protein ligand-responsive gate control
was embedded. The nanocomposite, named ’raspberry-type PoP’, was con-
structed by incorporating aSyn-functionalized AuNPs onto the surface of
a mesoporous silica nanoparticle (MSN) via acidic pH-induced non-
covalent interaction of aSyn on hydrophilic surface, which provides con-
trolled release behavior of its entrapped cargo mediated by ligand interaction
to the protein. The PoP on which 5 nm AuNP was incorported could
retain about 30% of pre-soaked Rh6G within MSN by blocking leaking-
out of the dye, and the percentage was dramatically decreased as AuNP
size increased. Thus, by tuning sizes of pore and/or surface nanoparticles,
one can improve the efficiency of cargo entrapment. Because of human-
originated a-Syn on the surface of the PoP, non-specific adsorption of plasma
proteins that enhance renal and immunological clearance of intravenously-
injected drug carriers might be prevented. The PoP released its entrapped
dye in response to interaction of various ions with aSyn. Particularly, Ca2þ
whose cytoplasmic concentration is tightly controlled could play as a key to
open the AuNP-aSyn gate, suggesting the potential application of the PoP
delivery system in Ca2þ-involved diseases such as cancers and cardiovascular
diseases.
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Thermally induced oxidative decomposition of iron(II) acetate in air is pre-
sented as a simple route towards superparamagnetic maghemite nanoparticles
the size of which can be controlled by the reaction temperature in the range of
320-400C. Decomposition mechanism, the phase composition of the reaction
products as well as their structural, magnetic and surface properties were
monitored by Mo¨ssbauer spectroscopy, XRD, TEM, magnetic and BET sur-
face area measurements. Mo¨ssbauer spectra confirm maghemite (gamma-
Fe2O3) as the only crystalline decomposition product without any traces of
other Fe2O3 polymorphs or magnetite (Fe3O4). On the other hand, the amor-
phous phase was identified in all samples, which is manifested by the presence
of the sextet component with significantly reduced hyperfine magnetic field in
the low temperature and in-field Mo¨ssbauer spectra. Its content decreases with
temperature of synthesis, in accordance with increasing saturation magnetiza-
tion of the samples. The size of maghemite particles can be controlled by re-
action temperature from 4-8 nm at 320 C to 20-30 nm at 400 C. This
controlled growth is clearly observed by TEM and indirectly demonstrated
by narrowing of XRD lines, decreasing surface area (from 147 to 51 m2/g)
and increasing blocking and irreversibility temperatures in the FC-ZFC
curves. The low intensities of the 2nd and 5th spectral lines in the in-field
(5K/5T) Mo¨ssbauer spectrum of the sample prepared at 400 C indicate a
low degree of spin frustration of maghemite phase, while the amorphous
admixture reveals speromagnetic behavior with unchanged intensities of spec-
tral lines compared to the zero-field spectrum. The sample synthesized at
400 C exhibits the MRI contrast properties fully comparable with the com-
mercial agent Lumirem as proved by phantom experiments.
